Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily K Moore

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|August 1, 2022
Combination Approaches to Target PD-1 Signaling in CancerEmily K Moore, Marianne Strazza, Adam Mor
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growthMarianne Strazza, Emily K Moore, Kieran Adam, et al.
Scientific Reports|September 27, 2019
Prolonged exposure to simulated microgravity diminishes dendritic cell immunogenicityNichole Tackett, Jillian H Bradley, Emily K Moore, et al.
Molecular Therapy. Oncology|July 29, 2024
Exclusion of PD-1 from the immune synapse: A novel strategy to modulate T cell functionLuke Yi Hao, Shalom Lerrer, Matthieu Paiola, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
PAG orchestrates T cell immune synapse function by binding to actinEmily K Moore, Marianne Strazza, Xizi Hu, et al.
JCI Insight|December 8, 2017
Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus controlAnnelise Y Mah, Armin Rashidi, Molly P Keppel, et al.
JCI Insight|December 8, 2022
An ELF4 hypomorphic variant results in NK cell deficiencySandra Andrea Salinas, Emily M Mace, Matilde I Conte, et al.
Cancer Cell|June 16, 2023
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunityPatricia Ho, Johannes C Melms, Meri Rogava, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|August 1, 2022
Combination Approaches to Target PD-1 Signaling in CancerEmily K Moore, Marianne Strazza, Adam Mor
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growthMarianne Strazza, Emily K Moore, Kieran Adam, et al.
Scientific Reports|September 27, 2019
Prolonged exposure to simulated microgravity diminishes dendritic cell immunogenicityNichole Tackett, Jillian H Bradley, Emily K Moore, et al.
Molecular Therapy. Oncology|July 29, 2024
Exclusion of PD-1 from the immune synapse: A novel strategy to modulate T cell functionLuke Yi Hao, Shalom Lerrer, Matthieu Paiola, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
PAG orchestrates T cell immune synapse function by binding to actinEmily K Moore, Marianne Strazza, Xizi Hu, et al.
JCI Insight|December 8, 2017
Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus controlAnnelise Y Mah, Armin Rashidi, Molly P Keppel, et al.
JCI Insight|December 8, 2022
An ELF4 hypomorphic variant results in NK cell deficiencySandra Andrea Salinas, Emily M Mace, Matilde I Conte, et al.
Cancer Cell|June 16, 2023
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunityPatricia Ho, Johannes C Melms, Meri Rogava, et al.
Pageof 1